Clinical Trial Update: Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing micafungin to fluconazole for invasive candidiasis and candidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Diflucan (Fluconazole)
• Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Invasive Candidiasis, Candidemia | Phase 3 | Status: COMPLETED